Search for: "Allergan Plc"
Results 21 - 40
of 43
Sort by Relevance
|
Sort by Date
16 Nov 2017, 6:17 am
Company Name Annual Director Retainer Regeneron Pharmaceuticals $2,074,085 Tesla $1,664,928 The Goldman Sachs Group $575,000 Salesforce.com $550,000 Celgene Corporation $524,871 Reynolds American $496,480 Valeant Pharmaceuticals International $475,000 Allergan PLC $450,000 Everest Re Group, Ltd. $447,030 Oracle $429,172 (more…) [read post]
26 Sep 2017, 12:46 pm
., Janssen Pharmaceuticals Inc. and Allergan PLC, filed a brief Friday saying they’ve complied with the U.S. [read post]
4 Jan 2017, 8:26 am
It is well-known that the DOJ has been investigating generic drug companies for approximately two years, and as a result of the disclosure of those investigations, shareholder class action lawsuits began being filed in November 2016 against manufacturers Endo International, plc, Allergan plc and various predecessors and executives. [read post]
4 Jan 2017, 8:26 am
It is well-known that the DOJ has been investigating generic drug companies for approximately two years, and as a result of the disclosure of those investigations, shareholder class action lawsuits began being filed in November 2016 against manufacturers Endo International, plc, Allergan plc, and various predecessors and executives. [read post]
21 Dec 2016, 7:18 am
The Patent Trial and Appeal Board (PTAB) of the United States Patent and Trademark Office (USPTO) recently instituted six separate inter partes reviews (IPRs) against patents owned by Allergan plc (NYSE: AGN), which cover RESTASIS® (Cyclosporine Ophthalmic Emulsion) 0.05%. [read post]
13 Dec 2016, 4:15 am
Last week the Patent Trial and Appeal Board (PTAB) of the United States Patent and Trademark Office (USPTO) instituted six separate inter partes reviews (IPRs) against patents owned by Allergan plc, which cover RESTASIS®. [read post]
8 Nov 2016, 11:53 pm
First, on November 4, plaintiffs’ lawyers filed a securities class action lawsuit in the Central District of California against Allergan plc, Allergan’s predecessor company Actavis plc, and certain of its Allergan’s directors and officers. [read post]
18 Apr 2016, 12:49 pm
The complaint also names Allergan plc, the parent company of Watson, and Endo International plc, the parent company of Endo Pharmaceuticals Inc. [read post]
6 Apr 2016, 7:37 pm
Pfizer Inc. and Allergan PLC withdrew their planned $160 billion merger, ending what would have been the largest so-called inversion transaction. [read post]
21 Dec 2015, 3:00 am
Marian (UC-Irvine), Inversions and Competitiveness: Reflections in the Wake of Pfizer/Allergan: The recent announcement that Pfizer Inc. has reached a merger agreement with Allergan PLC , with the combined entity being tax-resident in Ireland, is a good occasion to reconsider U.S. policy options... [read post]
30 Nov 2015, 6:11 am
The situation, which ultimately resulted in the acquisition of Allergan by Actavis plc, included a novel structure that involved a “partnership” between Valeant and the investment fund Pershing Square. [read post]
23 Nov 2015, 2:05 pm
Sales LLC, a subsidiary of pharmaceutical manufacturer Warner Chilcott PLC, has agreed to plead guilty to a felony charge of health care fraud, the Justice Department announced today. [read post]
15 Nov 2015, 9:32 pm
.; Allergan PLC Infringement of U.S. [read post]
10 Sep 2015, 5:47 pm
Flash forward one hundred or so years and look at the recent Pfizer case in England:From Bloomberg:Pfizer Inc. was accused by a U.K. judge of making “groundless threats” of legal action against British doctors and drugstores if they prescribed or sold a generic version of its best-selling Lyrica treatment.Judge Richard Arnold issued the rebuke as he ruled that Allergan Plc’s Actavis unit didn’t infringe Pfizer patents with its version of the drug… [read post]
19 Apr 2015, 9:56 pm
• Defendants: Allergan, Inc.; Actavis, PLC.; Allergan Sales, LLC Infringement of U.S. [read post]
21 Mar 2015, 6:26 am
Actavis plc (NYSE:ACT), No. 1:14-cv-00882 (D. [read post]
1 Dec 2014, 6:05 am
On November 17, 2014, Allergan, Inc. announced a $66 billion merger agreement with Actavis plc, thwarting the pending $53 billion bid for Allergan by Valeant Pharmaceuticals International Inc. [read post]
9 Mar 2014, 9:31 pm
Actavis plc et al. 2:14-cv-00188; filed March 6, 2014 in the Eastern District of Texas • Plaintiff: Allergan, Inc. [read post]
6 Mar 2014, 12:41 pm
Glaxo Wellcome PLC, 246 F.3d 934 (7th Cir. 2001). [read post]
12 Feb 2013, 1:00 pm
Allergan USA, Inc., 2012 N.J. [read post]
